IMBiotechnologies’ core product, Ekobi Embolization Microspheres, is a biodegradable embolic agent that is detectable by ultrasound and approved in the U.S. to treat inoperable hypervascularized tumors, according to a June 12 press release.
Medicus was founded by a group of physicians and partners with vascular ASCs and office-based labs.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.